Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma

• Published in: Virchows Archiv : an international journal of pathology 2023-08, Vol.483 (2), p.237-243
• Main Authors: Fritchie, Karen J., Dermawan, Josephine K., Astbury, Caroline, Sharma, Anurag, Bakhshwin, Ahmed, Fuller, Lanisha, Agrawal, Shruti, Wieland, Carilyn N., Greipp, Patricia T., Azzato, Elizabeth M., Folpe, Andrew L., Billings, Steven D.
• Format: Article
• Language: English
• Subjects: Abdominal wall; Adrenal glands; ALK protein; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics; Cysts; DNA-Binding Proteins - genetics; Fluorescence in situ hybridization; Gastrointestinal system; Gastrointestinal tract; Gene rearrangement; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Medicine; Medicine & Public Health; Neoplasms; Neurilemmoma - genetics; Neurilemmoma - pathology; Next-generation sequencing; Original Article; Pathology; Receptor Protein-Tyrosine Kinases - genetics; RNA-Binding Proteins - genetics; S100 protein; Schwann cells; Skin Neoplasms - genetics; Sox10 protein; Tumors
• ISSN: 0945-6317; 1432-2307
• DOI: 10.1007/s00428-023-03605-7

Microcystic/reticular schwannoma (MRS) is a benign variant of schwannoma with a predilection for the gastrointestinal tract and skin. To date, genetic characterization of this tumor is limited. Prompted by the identification of TFE3::NONO fusion and ALK overexpression in an index case of MRS, a cohort of tumors was collected from institutional and consultation archives of two institutions. Next-generation sequencing (NGS), TFE3 fluorescence in situ hybridization (FISH), and TFE3 and ALK immunohistochemistry were performed, while clinicopathologic variables were documented. Eighteen MRS cases were identified (35 to 85 years) arising in the skin ( n =8), gastrointestinal tract ( n =5), adrenal gland ( n =3), abdominal wall ( n =1), and unknown site ( n =1). Tumors showed a circumscribed to multinodular to plexiform low-power architecture with variable amounts of microcystic/reticular and solid schwannian components. Mitotic figures were scarce (0-1/10 HPFs), and atypia was absent. S100 protein and/or SOX10 immunoreactivity was noted in the microcystic/reticular and schwannian areas of all cases. NGS performed on two cutaneous tumors yielded NONO exon 12 fusion with TFE3 exon 4, and these lesions also showed HMB45 and ALK expression. Two additional cases showed ALK expression (1 weak), while a third was positive for TFE3, but these cases failed to show ALK or TFE3 rearrangement by FISH/NGS. There were no morphologic variables that correlated with the presence of NONO::TFE3 . We identified a subset of microcystic/reticular schwannomas with NONO::TFE3 fusions and ALK co-expression, adding to the cohort of mesenchymal neoplasms that show ALK overexpression without rearrangement of the ALK gene.